Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of clindamycin hydrochloride vaginal insert for bacterial vaginosis
ISRCTN33336878Phase 2Terminated
- Sponsor
- Controlled Therapeutics (Scotland) Limited
- Start
- Apr 2007
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in bacterial vaginosis (BV) comparing Clindamycin hydrochloride vaginal insert with Placebo vaginal insert (2 arms). Primary endpoint: Therapeutic cure rate of bacterial vaginosis. Started Apr 2007; status: terminated.
02
Drugs
clindamycin
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on ISRCTN33336878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN33336878.